INDUS (INH) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
12 May, 2026Executive summary
Revenue rose 9.7% year-over-year to EUR 441.6 million in Q1 2026, with all segments contributing and Materials Solutions showing the strongest increase.
Adjusted EBITA increased 70.7% to EUR 42.5 million, with margin up to 9.6%, driven by exceptional market conditions in Materials Solutions.
Earnings per share remained stable at EUR 0.64.
Working capital and net financial liabilities increased sharply due to higher raw material costs, especially tungsten carbide.
Two acquisitions completed: PRO VIDEO (consolidated from February 2026) and AMIRA (closed in April 2026).
Financial highlights
EBIT rose to EUR 36.0 million (prior year: EUR 19.6 million), with EBIT margin improving to 8.2%.
EBITDA increased 44.2% to EUR 61.3 million; EBITDA margin improved to 13.9%.
Free cash flow declined to EUR -74.1 million from EUR -23.6 million year-over-year due to higher working capital and inventory build-up.
Equity increased by EUR 19.5 million to EUR 750.2 million, with equity ratio at 38.7%.
Cash and cash equivalents decreased to EUR 119.8 million (Dec 2025: EUR 217.6 million).
Outlook and guidance
Group revenue guidance for 2026 raised to EUR 1.85–2.05 billion (previously EUR 1.80–1.95 billion).
Adjusted EBITA guidance increased to EUR 160–190 million, margin expected at 8.0–10.0%.
Free cash flow guidance revised to at least break-even (previously above EUR 70 million).
Segment guidance: Engineering and Infrastructure expect moderate to strong increases; Materials Solutions now expects strong increases in both revenue and earnings.
Latest events from INDUS
- Revenue up, free cash flow strong, and higher dividend proposed amid moderate growth outlook.INH
Q4 202527 Mar 2026 - Sales and EBIT fell, but EPS and free cash flow rose; guidance lowered amid economic headwinds.INH
Q2 20242 Mar 2026 - Sales stable, margins pressured by tariffs; guidance and strong H2 outlook confirmed.INH
Q2 20252 Mar 2026 - Record Q3 revenue and 10% EBITA growth, with guidance reaffirmed amid economic headwinds.INH
Q3 202512 Nov 2025 - Targeting EUR 3 billion sales by 2030, INDUS drives growth via acquisitions and resilient cash flow.INH
16th IIF - International Investment Forum8 Oct 2025 - Sales and EBIT fell year-over-year, but Q3 margins and cash flow improved.INH
Q3 202413 Jun 2025 - INDUS pursues ambitious growth to EUR 3 billion sales by 2030 through M&A and innovation.INH
CMD Presentation6 Jun 2025 - Sales and earnings fell, but order intake and equity ratio improved in Q1 2025.INH
Q1 20255 Jun 2025 - 2024 results met guidance, with resilient EBIT, improved equity ratio, and strategic acquisitions.INH
Q4 20245 Jun 2025